Menu
×
ADVERTISEMENT
ADVERTISEMENT

Novartis

Novartis breast cancer drug helped delay return of disease

Novartis breast cancer drug helped delay return of disease

16 September 2024, 10:27 IST
Bausch + Lomb to buy Novartis eye drop for $1.75 billion

Bausch + Lomb to buy Novartis eye drop for $1.75 bn

30 June 2023, 13:10 IST
India's cardiac sector in for major disruptions as top Novartis heart drug set to go off patent: Report

India's cardiac sector in for major disruptions: Report

04 December 2022, 09:46 IST
First-ever licencing deal struck for cancer drug

First-ever licencing deal struck for cancer drug

20 October 2022, 10:07 IST
Novartis slashes 8,000 jobs worldwide

Novartis slashes 8,000 jobs worldwide

29 June 2022, 09:10 IST
Novartis cuts uneasy 20-year ties to Roche with $20.7 bn voting stake sale

Novartis sells voting stake sale to Roche for $20.7 bn

04 November 2021, 14:16 IST
Novartis says may divest generic drugs unit Sandoz

Novartis says may divest generic drugs unit Sandoz

26 October 2021, 10:40 IST
Novartis signs new deal to help produce Pfizer-BioNTech vaccine

Novartis signs deal to produce Pfizer-BioNTech vaccine

21 October 2021, 10:29 IST
4 more Indian pharmaceutical firms expected to start vaccine production by Oct-Nov, says Mansukh Mandaviya

'4 more Indian firms may soon start vaccine production'

03 August 2021, 11:19 IST
Novartis India Q4 net profit rises 43% to Rs 9.7 crore

Novartis India Q4 net profit rises 43% to Rs 9.7 crore

17 June 2021, 15:07 IST